financetom
Business
financetom
/
Business
/
Fintech giant Stripe to buy crypto startup Bridge
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fintech giant Stripe to buy crypto startup Bridge
Oct 22, 2024 12:46 PM

Oct 21 (Reuters) - Stripe will buy stablecoin

infrastructure provider startup Bridge, the fintech said in a

tweet on Monday without disclosing the deal value.

The deal is valued at $1.1 billion, Forbes reported last

week, citing people familiar with the matter.

Stripe declined to comment on the transaction's value when

contacted by Reuters.

Stripe, founded by billionaires John Collison and Patrick

Collison in 2010, was valued at $65 billion earlier this year

and is among the highest valued private startups in the U.S.

Digital currencies are gaining traction after the U.S.

Securities and Exchange Commission allowed bitcoin spot

exchange-traded funds earlier this year, easing scrutiny and

paving way for cryptocurrencies to be accepted by major firms.

Last year, PayPal launched a U.S. dollar stablecoin to

become the first major financial technology company to adopt

digital currencies for payments and transfers.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Andlauer Healthcare to Launch Normal Course Issuer Bid
Andlauer Healthcare to Launch Normal Course Issuer Bid
Jun 27, 2024
09:00 AM EDT, 06/27/2024 (MT Newswires) -- Andlauer Healthcare Group ( ANDHF ) said Thursday that it secured TSX approval for a normal course issuer bid (NCIB) for up to 10% of its public float over the next 12 months. The company said it can purchase its shares for cancellation beginning on July 2 and until July 1, 2025. Andlauer...
Verona Pharma's inhaled COPD therapy to be priced at $2,950 per month
Verona Pharma's inhaled COPD therapy to be priced at $2,950 per month
Jun 27, 2024
June 27 (Reuters) - Verona Pharma's therapy for treating a chronic lung disease will be sold in the U.S. at a wholesale price of $2,950 per month, the U.K.-based company said on a conference call on Thursday. The U.S. health regulator's assent on Wednesday for the therapy, branded as Ohtuvayre, provides a new inhaled non-steroidal treatment for chronic obstructive pulmonary...
Spice maker McCormick beats quarterly results on strong EMEA business
Spice maker McCormick beats quarterly results on strong EMEA business
Jun 27, 2024
(Reuters) - McCormick ( MKC ) beat market expectations for second-quarter profit and sales on Thursday, led by strong demand for its spices and seasonings in Europe, Middle East and Africa. Customers grappling with still-high costs preferred cooking at home to dining out, improving volumes across the company's consumer segment, its biggest unit. Consumer sales in Europe, Middle East and...
BRIEF-Argonautic Ventures Says Preliminary Non-Binding Proposal To Benson Hill's Board Related To Proposed Acquisition By To-Be-Formed Acquisition Vehicle
BRIEF-Argonautic Ventures Says Preliminary Non-Binding Proposal To Benson Hill's Board Related To Proposed Acquisition By To-Be-Formed Acquisition Vehicle
Jun 27, 2024
June 27 (Reuters) - Benson Hill Inc ( BHIL ): * ARGONAUTIC VENTURES - PRELIMINARY NON-BINDING PROPOSAL TO BENSON HILL'S BOARD RELATED TO PROPOSED ACQUISITION BY TO-BE-FORMED ACQUISITION VEHICLE * ARGONAUTIC VENTURES-PROPOSAL TO BENSON HILL'S BOARD RELATED TO PROPOSED ACQUISITION ALL OF OUTSTANDING SHARES FOR CASH CONSIDERATION OF $0.2236/SHARE Source text for Eikon: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved